Bcpct]Ttsbc^Prc U^A Dq[XRV^^S
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
0 January to July 2021
0 www.journalsofindia.com January to July 2021 SCIENCE & TECH ............................................................................................................................................................... 6 1. REUSABLE LAUNCH VEHICLE TECHNOLOGY DEMONSTRATION PROGRAMME(RLV-TD) ................................................. 6 2. GAGANYAAN MISSION ..................................................................................................................................................... 6 3. MARS ORBITER MISSION (MOM) ..................................................................................................................................... 6 4. CHANDRAYAAN MISSION................................................................................................................................................. 7 5. SOLAR MISSION ............................................................................................................................................................... 8 6. ARTEMIS ACCORD ............................................................................................................................................................ 9 7. NATIONAL MISSION ON INTERDISCIPLINARY CYBER-PHYSICAL SYSTEM (NMICPS) ....................................................... 10 8. SMART ANTI-AIRFIELD WEAPON (SAAW) ...................................................................................................................... 10 9. AQUAPONICS ................................................................................................................................................................ -
COVID-19 Summary of Guidelines
[3] Table of Contents 1. Containment Plan for Large Outbreaks: Novel Corona Virus Disease 2019 (COVID-19 ............................... 7 2. Social Stigma Associated with COVID-19....................................................................................................... 7 3. Guidelines for Dialysis with reference to COVID 19 Infection ....................................................................... 7 4. Guidance document on appropriate management of suspect/ confirmed cases of COVID 19......................... 7 5. COVID - 19 testing laboratories approved and supported by ICMR as on 07/04/2020 ................................... 8 6. Railways meet half initial target in a quick time ............................................................................................... 8 7. DST supported healthcare startup developing rapid test for detection of COVID-19 .................................... 8 8. Check urgently the virus of misinformation on COVID-19: Vice President .................................................... 8 9. Guidelines for Quarantine facilities................................................................................................................. 9 10. Advisory on use of Homemade Protective Cover for Face & Mouth .............................................................. 9 11. Advisory to start rapid antibody-based blood test for COVID-19 .................................................................. 9 12. MHA writes to States/UTs to ensure smooth Disbursal of Money to beneficiaries -
Ifs Recommendations for Covid 19 Vaccination Before Art
16 – 17 JULY 2020 PRAGATI MAIDAN - DELHI INDIAN FERTILITY SOCIETY IFS RECOMMENDATIONS FOR COVID 19 VACCINATION BEFORE ART IFS SECRETARIAT +91 11 40018184 +91 9899308083 indianferlitysociety [email protected] www.indianferlitysociety.org indianferlitysociety 302, 3rd Floor, Kailash Building, ifsdelhi 26, Kasturba Gandhi Marg, C.P. New Delhi - 110001 Cosmo Tech is the Most Important Trade show for the Suppliers to EXPAND Strengthen Increase Multiply Profits New Markets Pan New Market Customer Base India & World Customer Soaring Boost Network Brand Sales Brand Recall Value with the Industry Visibility ORGANIZED BY CALL EMAIL +91 9971811937 [email protected] +91 9999302797 [email protected] +91 9811141938 [email protected] W W W .C O SMO TEC HEXPO IND IA .C O M Dr. Sudha Prasad Dr. Neena Malhotra President Secretary General Indian Fertility Society Indian Fertility Society Director, Matritava Advanced IVF & Professor, ART Centre, Department of Training Cenre, Vasant Vihar, New Delhi Obstetrics and Gynaecology, AIIMS, New Delhi Dr. Sonia Malik Dr. Kuldeep Jain Past President Indian Fertility Society, Past President Indian Fertility Society, Director & Nova Southend Fertility & Director, KJIVF New Delhi IVF Delhi NCR Dr. KU Kunjumoideen Dr. A K Pandey Joint Secretary Indian Fertility Society, Dean Academics &. Co Ordinator Director ARMC IVF Calicut. Molecular Lab. ESI Medical college Faridabad Dr. Charu Jandial Dr. Sumita Aggarwal Member IFS, Consultant, Member IFS, Fellow, Nova Southend Fertility & IVF Delhi NCR Nova Southend Fertility & IVF Delhi NCR Introduction The coronavirus pandemic has wreaked havoc on life In these trying mes, as sociees are gradually trying to and healthcare globally. According to WHO database as return to a state of normalcy, it is also important to on 7th June 2021, there have been 173 million consider sexual and reproducve health of people. -
Class Ix Female Sc
Lottery Rank REGISTRATION_ID NAME FATHERSNAME DOB Random 1 309839 SHWETA CHANDRA JAICHAND RAM 17-08-2008 0.999176 2 275040 SHABNAM RAJESH RAM 03-10-2006 0.99884 3 200350 SNEHA KANNAUJIYA VIKRAM KANNAUJIYA 20-09-2008 0.996185 4 212660 SUMAN RAJ BACHHA KUMAR RAJAK 27-11-2007 0.995453 5 257240 ANJU GAUTAM PAPPU RAM 01-01-2008 0.995392 6 233547 RINESHA SINGH KAMLA SINGH 01-03-2007 0.994568 7 301190 KOMAL BHARTI AMARNATH RAM 01-01-2008 0.994324 8 209614 VEENA KUMARI BABBAN RAM 10-01-2008 0.994263 9 224403 VAISHNAVI SONKAR VIKASH SONKAR 16-08-2007 0.992798 10 317964 SIMRAN KUMARI ABHAY KUMAR 20-10-2006 0.992615 11 329197 KAJAL BHARATI HARISHCHAND RAM 02-02-2007 0.988495 12 258643 NIKITA RAV NAVIN KUMAR RAV 16-10-2006 0.987518 13 292698 AKANKSHA SUSHIL KUMAR 01-01-2008 0.985931 14 261769 TULIKA RAMAWADH 01-01-2007 0.985443 15 274044 MAUSAM KUMARI ASHOK KUMAR 05-06-2007 0.985015 16 317987 RIYA KUMARI AMIT KUMAR 06-03-2008 0.984161 17 253652 RAGINI RAJENDRA 19-04-2008 0.983489 18 316478 NANDINI KUMARI SANJAY KUMAR DAS 16-03-2008 0.97998 19 295603 SHIVANI DHANANJAY KUMAR 10-12-2007 0.979797 20 318455 SOUMYA LAL SANTOSH LAL 01-12-2006 0.979522 21 239433 HARSHITA . PRADEEP KUMAR 10-03-2008 0.97821 22 286927 SNEHA DINESH KUMAR 01-01-2008 0.977935 23 227300 PRIYA KUMARI PRAMESH KUMAR RAM 08-07-2008 0.977721 24 256181 NITYA MANOJ KUMAR BHARTI 27-03-2008 0.977691 25 316779 SHALINI RAM NARENDRA 01-12-2007 0.976592 26 212440 MUSKAN KUMARI SHUBHASHCHANDRA GUPTA 05-04-2008 0.974731 27 321186 SUDIKSHA BHARTI SHYAM SUNDAR BHARTI 10-01-2008 0.974334 28 196717 -
HYDERABAD, SATURDAY, JUNE 5, 2021; PAGES 12 `3 RNI No
Follow us on: @TheDailyPioneer facebook.com/dailypioneer HYDERABAD, SATURDAY, JUNE 5, 2021; PAGES 12 `3 RNI No. TELENG/2018/76469 Established 1864 Published From HYDERABAD DELHI LUCKNOW BHOPAL RAIPUR CHANDIGARH BHUBANESWAR RANCHI DEHRADUN VIJAYAWADA *LATE CITY VOL. 3 ISSUE 226 *Air Surcharge Extra if Applicable www.dailypioneer.com Managed second wave, P RBI keeps interest rates unchanged P ‘Keen on signing scripts P ‘very well’; ready for 3rd: NITIA that are fun 5 announces measures to aid economy 8 entertaining, challenging’ 11 In brief IMPORT VACCINE, SAVE Petrol crosses Etela quits Assembly, TRS Pfizer vaccine for Rs 100/litre Ex-minister confirms he would be joining BJP; 12-15 age group PEOPLE, KTR TELLS CENTRE mark in TS, AP launches no-holds-barred attack on KCR gets nod in the UK ML MELLY MAITREYI ritain's medicines regulator said PNS n HYDERABAD PNS n NEW DELHI n HYDERABAD Friday the Pfizer/BioNTech B vaccine is safe for adolescents Minister KT Rama Rao on Friday After Rajasthan, Madhya Pradesh Former minister Etela Rajender let aged 12 to 15 after a "rigorous review", targeted the Centre again for its and Maharashtra, petrol price the suspense over his political following similar assessments in the “bungling” on Covid-19 vaccina- has crossed the Rs 100-per-litre future hang for some time even as EU and US."We have carefully tion and demanded that it imme- mark in almost all districts of AP he resigned from the Membership reviewed clinical trial data in children diately import vaccines from coun- and parts of Telangana after fuel of the State Legislative Assembly aged 12 to 15 years and have tries that are sitting on a huge prices were again hiked on Friday. -
Overview of Aarogya Setu Application Shweta Devidas Kedare1
International Research Journal of Engineering and Technology (IRJET) e-ISSN: 2395-0056 Volume: 07 Issue: 06 | June 2020 www.irjet.net p-ISSN: 2395-0072 Overview of Aarogya Setu Application Shweta Devidas Kedare1 1Shweta Devidas Kedare, Department of Master of Computer Application, ASM IMCOST, Maharashtra, India ---------------------------------------------------------------------***--------------------------------------------------------------------- Abstract - The app - Aarogya Setu, which means "bridge to health" in Sanskrit -It is an Indian app which was launched on April 2nd 2020, by Indian government. It is designed as a Coronavirus, or COVID-19 contact tracing app that uses the Bluetooth and location technology in phones to note when you are near another user who also uses the Aarogya Setu app. In case someone you have come in close proximity to is confirmed infected, you are alerted. The app alerts are produced by instructions on how to self-isolate and what to do in case you develop symptoms. Basically this app gives basic information about Covid-19, including hygiene and social distancing protocols. It also has details of how one could donate to the prime minister’s coronavirus-specific relief fund, PM-Cares. India has made it mandatory for government and private sector employees to download it But users and experts in India and around the world say the app raises huge data security concerns. KeyWords: security, data, private, information, COVID-19, technology, location, bluetooth, proximity, etc. 1. INTRODUCTION Since the risk of COVID-19 started increasing in India so, The government of India decided to launch the application, name Aarogya Setu, which was intended to monitor the ratio of COVID-19 patients in India .This app is an updated version of an earlier app called Corona Kavach (now discontinued) which was released earlier by the Government of India. -
A Review of India's Contact-Tracing App, Aarogya Setu
Doc Title A Review of India’s Contact-Tracing App, Aarogya Setu A - Front Page two line title ARTICLE A Review of India’s Contact-tracing App, Aarogya Setu The Government of India’s Ministry of Electronics and Information Technology (MeitY) agency launched Aarogya Setu, a contact-tracing mobile application. Aarogya Setu has been created by the National Informatic Centre (NIC) in response to the COVID-19 crisis, as a way to collect and understand public health-related data.1 The application uses mobile phones to perform a cross reference of individuals’ data with the database held by Indian Council of Medical Research (ICMR), “On various online discussion which was specially created as part of ongoing COVID-19 testing infrastructure. forums, there is significant The purpose of Aarogya Setu is to notify users whether they have been exposed interest in the workings of this to COVID-19, by checking their proximity to known patients. In the event of a government- managed app match, the application will warn other users in the area that an infected person and its use of personal and is in their proximity. According to the press release dated May 26, 2020 available sensitive user data..”123 on mygov.in website, roughly 114 million users have adopted the app.2 Aarogya Setu also collects some sensitive personal information including gender and recent travel information. This has raised privacy and security questions. This whitepaper evaluates the functionality and data privacy aspects of the application. About Aarogya Setu Aarogya Setu app is a self-assessment disease monitoring app launched by the Indian government. -
Covid-19 Tracing Contacts Apps: Technical and Privacy Issues
Int. J. Advance Soft Compu. Appl, Vol. 12, No. 3, November 2020 ISSN 2074-8523; Copyright © ICSRS Publication, 2020 www.i-csrs.org Covid-19 Tracing Contacts Apps: Technical and Privacy Issues Salaheddin J. Juneidi Computer Engineering Department, Palestine Technical University Khadoorei1, Hebron, West Bank Palestine. e-mail: [email protected] Received 20 July 2020; Accepted 5 October 2020 Abstract Since the start of the year 2020 the world is facing an outbreak of Covid-19 pandemic, technical specialists all over the universe have been scrambling to develop services, apps, and system’s protocols for contactors tracing, with the objective to identify and to notify everyone that gets close with an individual carrier. Some of these apps are lightweight and temporary, while others are diffuse and aggressive. Some of tracing services are developed locally by small interested programmers, while others are large-scale international operations. To date, we have recognized more than 25 large automated contact tracing efforts around the globe, included with details about what they were, how they worked, and the procedures and conditions that were put in place around them. This paper will deal with general data of the most prominent applications in terms of technical approaches used in the world and compare them with regard to the efficiency of tracking covid-19 and compare them with concerning of the people’s privacy who use these apps. Keywords: Covid-19, GPS location, Blue trace, Google/Apple, DP-3T, Apps, Privacy. 1. Introduction Many applications, services and systems have been proposed and launched [1] with an aim to track and identify infected people with objective to reduce or even to prevent physical contact with other people, some of these tracking 1 Special thanks to Palestine Technical University -Khadoorei for continuous support of research efforts Salaheddin J. -
LOK SABHA ___ BULLETIN – PART I (Brief Record of Proceedings) ___ Thursday, February 11, 2021/Magha 22, 1942 (Saka) ___
LOK SABHA ___ BULLETIN – PART I (Brief Record of Proceedings) ___ Thursday, February 11, 2021/Magha 22, 1942 (Saka) ___ No. 100 4.00 P.M. 1. Starred Questions Starred Question Nos. 141 and 143–145 were orally answered. Members in whose names Starred Question No. 142 was listed, were absent. However, Minister concerned laid the reply on the Table. Starred Question Nos. 152 and 157 were clubbed. Member in whose name Starred Question No. 152 was listed, was absent. However, Minister concerned laid the reply on the Table. Supplementary Question to Starred Question No. 157 was asked. Starred Question Nos. 146 and 154 were clubbed. Member in whose name Starred Question No. 146 was listed, was absent. However, Minister concerned laid the reply on the Table. Supplementary Questions to Starred Question No. 154 were asked. Replies to Starred Question Nos. 147–151, 153, 155, 156 and 158–160 were laid on the Table. 2. Unstarred Questions Replies to Unstarred Question Nos. 1611–1840 were laid on the Table. 2 3. Papers laid on the Table The Minister of State in the Ministry of Parliamentary Affairs; and Minister of State in the Ministry of Heavy Industries and Public Enterprises (Shri Arjun Ram Meghwal) on behalf of the Minister of Health and Family Welfare; Minister of Science and Technology; and Minister of Earth Sciences (Dr. Harsh Vardhan) laid on the Table a copy each of the following papers (Hindi and English versions):- (1) Detailed Demands for Grants of the Ministry of Health and Family Welfare for the year 2021-2022. (2) Output Outcome Monitoring Framework for GS & CSS Scheme of the Ministry of Health and Family Welfare for the year 2021-2022. -
Extend the Lockdown Till May 31, 2020
Press Information Bureau Government of India ***** Extension of Lockdown up to May 31, 2020 States to decide various Zones and Activities to be allowed in these Zones; Certain activities to remain prohibited throughout the Country National Directives for COVID-19 Management continue to be in force throughout the Country Night Curfew to continue to remain in force New Delhi, May 17, 2020 Lockdown measures in place since March 24, 2020 have helped considerably in containing the spread of COVID-19. It has therefore been decided to further extend the lockdown till May 31, 2020. Ministry of Home Affairs (MHA), Government of India (GoI) issued an order, today, under the Disaster Management (DM) Act, 2005, in this regard. The salient features of the new guidelines are as follows: States to decide various Zones Under the new guidelines, States and Union Territories (UTs) will now delineate Red, Green and Orange zones taking into consideration the parameters shared by the Health Ministry. The zones can be a district, or a municipal corporation/ municipality or even smaller administrative units such as sub-divisions, etc, as decided by States and UTs. Within the red and orange zones, containment and buffer zones will be demarcated by the local authorities, after taking into consideration the Health Ministry guidelines. Within the containment zones, only essential activities shall be allowed. Strict perimeter control shall be maintained, and no movement of persons would be allowed, except for medical emergencies and for maintaining supply of essential goods and services. Buffer zones are areas adjoining each containment zone, where new cases are more likely to appear. -
Ситуация По Вакцинам От Covid-19 В Мире. Вопросы Коммуникации С Населением По Вакцинации От Covid-19
Филиал «Научно-практический центр санитарно-эпидемиологической экспертизы и мониторинга» Ситуация по вакцинам от COVID-19 в мире. Вопросы коммуникации с населением по вакцинации от COVID-19 Алматы, 2021 г. Ситуация в мире по вакцинам против COVID-19 - Согласно данным Всемирной организации здравоохранения по состоянию на 19.01.2021 года в мире: - разрабатываются 237 вакцин-кандидатов: . из них проходят клинические стадии испытания - 64 вакцины . пре-клинические стадии проходят - 173 вакцин. используются 8 вакцин (Moderna, BioNTech / Pfizer, Oxford Biomedica и AstraZeneca, НИИ Гамалея (Спутник V), CanSino Biologics, Sinopharm (2), Sinovac / Instituto Butantan / Bio Farma). https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines Вакцины в мире Экстренно введенные В фазе 3 (20) В фазе 2 (21) В фазе 1 (43) вакцины • Moderna (США) • QazCovid in(Казахстан) • Medigen (Тайвань) • VIDO (Канада) • • • • Pfizer-BioNTech (Германия) SINOVAC (Китай) Arcturus (США) Genexine (Южная Корея) • Covaxin (Индия) • Спутник V (Gamaleya РФ) • Pfizer-BioNTech (Германия) • Walvax Biotechnology (Китай) • • • • AZD1222 (Британия-Франция) Clover Biopharmaceuticals (США) Gennova Biopharmaceuticals (Индия) ChulaCov19 (Китай) • West China Hospital of Sichuan • GeneOne Life Science (Южная Корея) • Covigenix VAX-001 (Канада) University (Китай) • Soberana 1 (Куба) • Symvivo (Канада) • mRNA-1273 (США) • COVAX (Франция) • CORVax12 (США) • CVnCoV (Германия) • SpyBiotech (Англия) • Vaxart (США) • AG0302-COVID19 (Япония) • Dynavax (США) • Merck (США) -
Privacy Framework for Aarogya Setu
Privacy Framework FOR the Aarogya Setu App Working Paper | Version 1.0 Privacy Framework for the Aarogya Setu App “Life is like the harp string, if it is strung too tight it won’t play, if it is too loose it hangs, the tension that produces the beautiful sound lies in the middle.” - Gautam Buddha Authors Pranav Bhaskar Tiwari1, Ayush Tripathi2, Harsh Bajpai3, Karthik Venkatesh4, Arya Tripathy5 & Kazim Rizvi6. 1 Policy Research Associate, The Dialogue 2 Policy Research Associate, The Dialogue 3 Research Scholar, Durham University 4 Strategic Engagement and Research Fellow, The Dialogue 5 Principal Associate, Priti Suri & Associates 6 Founding Director, The Dialogue © The Dialogue | 6.5.2020 1 Working Paper | Version 1.0 Index Executive Summary 3 Legal Challenges and Way Forward 3 Privacy Challenges and Way Forward 4 Recommendations 5 1. Background 6 1.1 COVID-19 Pandemic - A Socio-Economic Challenge 8 1.2 Technology as a resource to combat the outbreak 9 1.3 Citizen’s Participation Must - A Fundamental Duty to protect our Communities 10 1.4 Aarogya Setu 11 1.5 Right to Health and Right to Privacy to be harmonised 11 1.6 Proportionality at the heart of Reasonable Restrictions 12 2. Privacy Central to Mass Deployment of the App 14 2.1 Citizen Trust is Critical 14 2.2 Immediate Solution Vs. Preventing Future Harm? 16 2.3 Community Rights Vs. Individual Rights 17 3. The Privacy Framework 19 3.1 Legality 26 3.2 Transparency and Verifiability 20 3.3 Voluntariness 26 3.4 Data Minimisation 26 3.5 Anonymisation 26 3.6 Storage of Data 26 3.7 Grievance Redressal Mechanism & Accountability 26 3.8 Sunset Clause 27 3.9 Access to Data 28 3.10 Data Sharing 29 3.11 Integration of Data Sets 30 3.12 Scope/Function Creep 31 3.13 Auditing 31 3.14 Public Confidence 32 © The Dialogue | 6.5.2020 2 Working Paper | Version 1.0 Executive Summary Technology is one of the tools in the fight against the pandemic and Governments around the world have been deploying technological solutions to tackle the threat posed by COVID-19.